The antimicrobial peptide, LL-37, has been implicated in the breaking of tolerance in psoriasis (4) and SLE (2) through the formation of complexes with self-DNAs which activate pDCs through TLR9 with increased retention in early endocytic compartments (4). This evidence concerns the gene TLR9 and systemic lupus erythematosus.